Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial electron transport chain (ETC) and cellular antioxidant systems constitute the primary machinery for cellular energy transduction and the maintenance of redox homeostasis. The ETC is composed of a series of protein complexes (I-IV) and electron carriers that facilitate oxidative phosphorylation to generate ATP, while the antioxidant systems—comprising enzymes like superoxide dismutase (SOD) and molecules like glutathione—protect the cell from the reactive oxygen species (ROS) generated during this process (StatPearls, 2023). Dysfunction in these systems is central to the pathogenesis of neurodegenerative diseases like Parkinson's, where mitochondrial failure leads to oxidative stress, and in cancer, where cells often rewire these pathways to survive in hypoxic environments (PubMed, 2021). Therapeutic strategies targeting this axis range from ETC inhibitors like metformin, which modulates Complex I, to mitochondrial-targeted antioxidants like MitoQ designed to reduce oxidative damage (NIH, 2022). Because these systems are fundamental to nearly all aerobic life, pharmacological intervention requires precise targeting to avoid systemic toxicity or the disruption of vital metabolic functions.
Modulation of electron flow through respiratory complexes, scavenging of reactive oxygen species, enhancement of endogenous antioxidant enzyme activity, and uncoupling of oxidative phosphorylation.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial electron transport chain and cellular antioxidant systems (ETC/AOS).